pomalidomide has been researched along with prednisolone in 3 studies
Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (prednisolone) | Trials (prednisolone) | Recent Studies (post-2010) (prednisolone) |
---|---|---|---|---|---|
623 | 121 | 552 | 34,414 | 3,302 | 7,141 |
Protein | Taxonomy | pomalidomide (IC50) | prednisolone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.0278 | |
Progesterone receptor | Homo sapiens (human) | 2.08 | |
Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0565 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.016 | |
Mineralocorticoid receptor | Homo sapiens (human) | 0.0322 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.016 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.016 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hogan, WJ; Hussein, K; Litzow, MR; Mesa, RA; Pardanani, AD; Schwager, S; Tefferi, A; Wu, W | 1 |
Iida, S | 1 |
Benner, A; Blau, IW; Döhner, H; Döhner, K; Gattermann, N; Grießhammer, M; Hebart, H; Heidel, FH; Hochhaus, A; Jost, E; Kreipe, H; Platzbecker, U; Reiter, A; Schafhausen, P; Schlenk, RF; Stegelmann, F; Teleanu, V; Verbeek, W; Waller, C; Werner, M | 1 |
1 review(s) available for pomalidomide and prednisolone
Article | Year |
---|---|
[Multiple myeloma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Denosumab; Diphosphonates; Humans; Imidazoles; Melphalan; Multiple Myeloma; Peripheral Nervous System Diseases; Prednisolone; Pyrazines; Randomized Controlled Trials as Topic; Thalidomide; Zoledronic Acid | 2012 |
2 trial(s) available for pomalidomide and prednisolone
Article | Year |
---|---|
Phase1/-2 study of Pomalidomide in myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Male; Maximum Tolerated Dose; Middle Aged; Prednisolone; Primary Myelofibrosis; Thalidomide | 2010 |
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Topics: Aged; Aged, 80 and over; Alleles; Biomarkers; Chromosome Banding; Female; Humans; Immunologic Factors; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenotype; Prednisolone; Primary Myelofibrosis; Thalidomide; Treatment Outcome | 2017 |